Vaxcyte, Inc. — Director's Dealing 2023

Oct 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2023-10-02

Reporting Person: PICKERING GRANT (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-02	Common Stock	S	641	$49.67	Disposed	155880	Indirect
2023-10-02	Common Stock	S	385	$50.76	Disposed	155495	Indirect
2023-10-02	Common Stock	S	283	$51.52	Disposed	155212	Indirect
2023-10-02	Common Stock	S	646	$49.68	Disposed	155875	Indirect
2023-10-02	Common Stock	S	221	$50.48	Disposed	155654	Indirect
2023-10-02	Common Stock	S	442	$51.55	Disposed	155212	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	400914	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F2: The price reported is a weighted-average price. The shares were sold at prices ranging from $49.205 to $50.025. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F4: The price reported is a weighted-average price. The shares were sold at prices ranging from $50.31 to $51.245. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: The price reported is a weighted-average price. The shares were sold at prices ranging from $51.505 to $51.565. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F6: The price reported is a weighted-average price. The shares were sold at prices ranging from $49.195 to $50.025. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F7: Shares are held directly by a trust for the benefit of the Reporting Person's son.

F8: The price reported is a weighted-average price. The shares were sold at prices ranging from $50.31 to $50.064. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F9: The price reported is a weighted-average price. The shares were sold at prices ranging from $51.39 to $51.69. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.